EpLink is the Epilepsy Research Program of the Ontario Brain Institute. We are an epilepsy research program focused on finding new ways to diagnose, treat and improve the lives of people living with drug-resistant epilepsy. Our program is funded by the Ontario Brain Institute and aims to bring health innovations directly to the epilepsy community.
To create health innovations that provide seizure freedom and improve quality of life for individuals with drug-resistant epilepsy.
Our goals include improving the diagnosis and treatment for drug-resistant epilepsy and improving the lives of people living with it. To do so, we have over 35 researchers working on research projects at eight institutions across Ontario, focusing on:
- Diet Therapy
- Epidemiology and Diagnosis
- Genetics and Epigenetics
- Drug Therapy
- Quality of Life
- Seizure Prediction and Brain Stimulation
- Seizure Surgery
Through our research effects, we hope to provide earlier diagnoses; more effective drug therapies, diet therapies and surgical procedures; new treatment options, such as gene therapy and brain stimulation; and ways to improve cognition, mood and quality of life for individuals living with uncontrolled seizures.
Our Management Committee
EpLink has a Management Committee that meets biweekly to provide input and guidance for EpLink’s research, public education and fundraising initiatives, and overall program. The Committee is composed of self-appointed EpLink researchers and staff, and a representative from Epilepsy Ontario. Together, the Committee helps to guide EpLink’s ongoing initiatives, ensuring they are cutting-edge and relevant to people living with epilepsy.
W. McIntyre Burnham, PhD
Professor Emeritus, University of Toronto
Jorge Burneo, MD, MSPH
Associate Professor and Co-Director of the Epilepsy Program, Western University
Kathryn Hum, PhD
- Community Advisory Committee
- Drug Development Committee
- Management Committee